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EDITORIAL REVIEW
Extracellular nucleotides as modulators of renal tubular transport
The pivotal role of nucleotides in cell function and metabolism
has been acknowledged for more than three decades since the
milestone work of Sutherland. Intracellular nucleotides are in-
volved in each and every event of cell life including synthesis of
nuclear material, phosphorylation processes, or transduction of
extracellular signals. As regards this last point, a huge amount of
studies has been devoted to identify the key role of GTP-binding
proteins or G proteins, on the one hand, and of cyclic nucleotides
cAMP and cGMP, on the other hand, in the early steps of cell
signaling. In epithelial cells such as renal tubular cells, generation
of these mediators as a hallmark of cell-hormone interaction has
been investigated in detail [reviewed in 1].
More recently, experimental evidence was provided showing
that extracellular nucleotides are able to affect virtually every
organ and/or tissue system. These aspects have been extensively
reviewed [2—6] and will not be discussed in detail below because
they are beyond the scope of this review. Instead, attention will be
focused on the modulation of membrane transport by extracellu-
lar nucleotides in mammalian cells, among which renal cells.
These observations, which suggest that nucleotides may act as
local, paracrine modulators of membrane transport, raise three
questions: (a) How do nucleotides reach the extracellular space;
(b) How are nucleotides "sensored" by neighbour cells; and (c)
What are the transport systems the activity of which is modulated
through this pathway.
In this review, each of these three points will be successively
discussed. When available, examples will be drawn from renal cell
physiology and compared with data obtained from other models
of non-renal cells.
How do nucleotides reach the tubular fluid?
Because cyclic and non-cyclic nucleotides are all generated
within the cell, a possible effect of these compounds from the
extracellular side, more specifically from the apical-luminal side of
tubular cells, raises the questions of how they exit from the cells,
which transport systems are involved, are these systems regulated
and are they inserted in a polarized fashion in the plasma
membrane of epithelial cells. The bulk of information concerns
cyclic nucleotides cAMP and cGMP and contrasts with the paucity
of data dealing with the egression routes of ATP.
Efflux of cAMP
Extrusion of cAMP from renal tubular cells into the tubular
lumen was suggested by the observation that urinay cAMP
excretion exceeds the filtered load except in the absence of
parathyroid hormone (PTH) [7—10]. The difference between
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excreted and filtered cAMP is commonly known as nephrogenous
cAMP, and is a sensitive and accurate marker of parathyroid
function [10, 11]. Micropuncture data demonstrate that the bulk
of cAMP added to the urine is transferred in the proximal
convoluted tubule [10]. It is very likely, therefore, that apical
transport of cAMP occurs in this nephron segment. The mecha-
nism of cAMP extrusion was examined in cultured LLC-PK1 cells,
a renal epithelial cell line which possesses a mixed proximal/distal
phenotype (Na-glucose cotransport, vasopressin-stimulated ad-
enylate cyclase and phospholipase C), grown on permeant sup-
ports [12]. Upon stimulation of adenylate cyclase, cAMP accumu-
lated mainly in the apical bath and, to a much lesser extent, in the
basolateral compartment [121. Apical cAMP effiux was tempera-
ture-dependent and was inhibited by probenecid, an organic anion
transport inhibitor, by metabolic and phosphodiesterase inhibi-
tors, but not by prostaglandins or cAMP analogs, suggesting that
protein kinase A was not involved in activation of cAMP efflux. In
contrast, the small basal cAMP efflux was insensitive to probene-
cid.
The identification of the mechanisms and modulation of cAMP
efflux from mammalian cells is not a topic which is restricted to
renal tubular cells and was also examined in non-polarized cells
such as erythrocytes or smooth muscle cells [13, 14]. In the latter,
sensitivity of cAMP efflux to probenecid and lack of modulation
by protein kinase A was evidenced. In smooth muscle cells, in
which cAMP generation was stimulated by adenosine, adenosine
receptor occupancy was mandatory for maintainance of cAMP
effiux, suggesting that an intracellular signaling system, distinct
from the cAMP-protein kinase A pathway, may be involved in
modulation of the activity of the cAMP transport system(s).
The question of whether urinary cAMP might originate in part
from plasmatic cAMP after tubular secretion from the peritubular
space to the lumen has been addressed in several studies with
conflicting results [15, 16]. It is very unlikely that the amount of
cAMP reaching the tubular lumen through this pathway, if any, is
substantial for at least two reasons: (i) the affinity of a basolateral
transport system of organic anions for cAMP is very low, in the
millimolar range [17], as compared to plasma concentration of the
cyclic nucleotide which is around 10 nM; (ii) renal clearance of
systemically infused tritiated cAMP equals glomerular filtration
rate, suggesting that plasmatic cAMP is purely filtered [15].
Efflux of cGMP
As regards cGMP, in vivo experiments demonstrated the exis-
tence of nephrogenous cGMP excretion in rats infused with atrial
natriuretic peptide (ANP) [18]. That luminal cGMP in excess to
the filtered load was originating from the Bowman space was
established by micropunctures [18]. The pattern of cGMP efflux
was examined in vitro in cultured SV4O-transformed human
glomerular visceral epithelial cells grown on filters [19, 20].
cGMP, generated under the influence of ANP, was exported
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almost entirely to the apical bath. Effiux was inhibited by probene-
cid and nocodazole, a microtubule disrupter, but not by cytocha-
lasin, an actin filament disrupter [201. This may suggest that apical
delivery of the transport system responsible for cGMP extrusion
was dependent on the integrity of the microtubule network [21].
The nature of the transport system(s) responsible for effiux of
cyclic nucleotides has not been established. As discussed above,
this transporter shares some properties with an organic acid
transporter inasmuch as both are sensitive to probenecid. In the
rat proximal tubule, the affinity of such a transporter for various
nucleotides has been examined [17] and was found to be much
greater for cGMP or for cAMP analogs than for cAMP. This
feature would account for an efflux of both cAMP and cGMP
despite the fact that intracellular concentration of cGMP is
usually much lower than that of cAMP [22]. Other candidates for
cyclic nucleotide transport through plasma membranes, among
which the cyclase itself, have been suggested on the basis of
topological similarities between this enzyme and channels or
transporters [23].
Efflux ofATP
While ATP is present in millimolar concentrations in the
cytosol of all cell types, extracellular concentrations are usually
maintained at very low levels. Cytosolic ATP may reach the
extracellular medium under several circumstances: (i) sudden
breakage of intact cells; (ii) exocytic release of packaged ATP
such as evidenced in platelets, mast cells, and basophilic leuko-
cytes; and (iii) release of cytosolic ATP via intrinsic plasma
membrane proteins which is increased by hypoxia [reviewed in 2].
The latter was shown to be attenuated by inhibitors of anion
transporters (stilbene derivatives) or of nucleoside transporters
(dipyridamole or nitrothiobenzylinosine).
Polarity of ATP effiux has not been evidenced. However, it was
recently reported that P-glycoprotein, the multidrug resistance
gene product which is located in brush border membranes of
proximal tubules [24], behaved like an ATP channel responsible
for ATP efflux [25]. This suggests that luminal ATP concentration
may reach values much higher that systemic ones, owing to water
substraction, provided that luminal ATP catabolism in distal parts
of the nephron is modest and that no back diffusion occurs.
However, direct measurements of ATP concentration in the
tubular fluid under different circumstances is currently lacking.
Many questions remain presently unanswered regarding the
routes of membrane nucleotide transport, their regulation by
hormones and mediators, the involvement of intracellular signal-
ing pathways and possible genetic or acquired abnormalities of
these steps. The low amount of data in this field contrasts with
numerous informations concerning both adenosine transport by
renal tubular plasma membranes [26—29] and degradation of
extracellular nucleotides in the tubular lumen by brush-border
membrane enzymes [301. It is likely that acknowlegment of
extracellular nucleotides as potent and ubiquitous modulators of
cell function will bring more attention on the transport systems
involved in exit of these compouns from mamalian cells.
Modulation of renal transport by luminal cyclic nucleotides
As discussed above, luminal concentrations of cAMP and
cGMP may increase upon stimulation of generating systems, that
is, PTH-sensitive adenylate cyclase and ANP-sensitive particulate
guanylate cyclase, respectively. In contrast, plasmatic (basolat-
eral) concentrations of cyclic nucleotides were shown to be fairly
constant under physiological circumstances [7, 181. This raises the
possibility that luminal nucleotides influence the activity of trans-
port systems in renal tubular cells.
Luminal CAMP and phosphate transport
The initial observations that infusion of cAMP to parathyroid-
ectomized rats mimicked the phosphaturia induced by PTH drew
attention on the effects of extracellular cAMP on renal function
[8, 31]. A striking feature was that other renal effects of PTH
(modulation of calcium or magnesium excretion) or renal effects
of other peptidic hormones which act through the cAMP-protein
kinase A pathway, such as antidiuteric hormone, were not repro-
duced by cAMP infusion [31]. Along the same line glucagon,
infused or injected at large pharmacological doses which induce a
rise of plasma cAMP concentration from hepatic origin and urine
excretion of the nucleotide [7, 8], was shown to increase phos-
phate excretion [8]. These data raised the possibility that handling
(metabolism and/or transport) of extracellular cAMP by proximal
cells was involved in the effect of the cyclic nucleotide.
To elucidate the mechanism underlying extracellular cAMP-
induced inhibition of proximal phosphate transport, in vitro
studies were performed in opossum kidney (OK) cells, a renal
epithelial cell line with proximal phenotype in which the activity of
Na-phosphate cotransport system is inhibited by PTH [32, 33]. In
these cells, addition of cAMP to the extracellular medium induced
an inhibition of sodium-phosphate cotransport activity [34]. The
effect of cAMP was blunted by agents which prevented extracel-
lular degradation of the nucleotide into adenosine, that is, inhib-
itors of phosphodiesterase, which converts cAMP to 5'-AMP, and
inhibitors of ecto-5 '-nucleotidase, which transforms 5 '-AMP into
adenosine. Moreover, adenosine uptake was a mandatory step in
the action of cAMP since dipyridamole, a well-known inhibitor of
adenosine uptake in many cell types including renal tubular cells
[26—28], abolished the effect of cAMP. Incubation of cells with
labeled cAMP confirmed that accumulated intracellular radioac-
tive material was first adenosine, followed by AMP, ATP, and
ultimately cAMP.
Intracellular steps following adenosine entry are not yet com-
pletely understood. It has been established that adenosine is
phosphorylated into ATP. This is the basis of the protective effect
of extracellular nucleotides against ATP depletion during isch-
emia [35, 36]. However, that conversion of intracellular adenosine
into ATP is instrumental in inhibition of phosphate uptake
remains to be demonstrated. Alternatively, adenosine may affect
phosphodiesterase activity and may thereby inhibit phosphate
transport [37, 38].
These results, obtained in OK cells, are in line with the previous
observation that rabbit proximal tubules in suspension catabolized
extracellular cAMP [39]. In vivo, the physiological relevance of
this pathway was assessed by the fact that dipyridamole infusion
reduced by approximately one third phosphate excretion in PTH-
infused parathyroidectomized rats or in intact rats [34]. We have
recently confirmed that this pathway was instrumental in humans
and that dipyridamole infusion decreased phosphate excretion in
normal subjects, in patients with primary hyperparathyroidism
and in hypophosphatemic patients with renal phosphate leak
unrelated to PTH hypersecretion [40]. This indicates that luminal
cAMP participates to the overall phosphaturic effect of PTH and
that nephrogenous cAMP, extruded into the tubular lumen in the
Peritubular space
PKA
-t cAMP
5-AMP
ADO
Tubular lumen
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Fig. 1. Mode of action of luminal cAMP on Pi transport. cAMP, either filtered by the glomeruli or extruded from tubular cells to the lumen, is catabolized
into adenosine which is uptaken by the cells and metabolized, cAMP produced from adenosine inhibits Na-Pi cotransport activity. PTH stimulates
membrane-bound 5'-nucleotidase activity via PKC activation. Abbreviations are: AC, adenylate cyclase; ADO, adenosine; DAG, diacylglycerol; PKA,
protein kinase A; PKC, protein kinase C; PLC, phospholipase C; PDE, phosphndiesterase; 5'-NU, 5'-nucleotidase; PTH, parathyroid hormone. Thick
unbroken arrows denote stimulatory effect, thick dotted arrows denote inhibitory effect.
proximal convoluted tubule under the influence of PTH, acts
downstream, most likely in the proximal straight tubule, to
modulate sodium-phosphate cotransport activity in this segment.
Furthermore, data in humans suggest that pharmacological inhi-
bition of adenosine uptake may be useful to reduce renal phos-
phate leak.
It is noteworthy that a somewhat similar metabolic cascade has
been evidenced in the intestinal epithelium during intestinal
inflammatory diseases [41]: activated neutrophils located in the
lumen release 5'-AMP which is converted to adenosine by ecto-
5'-nucleotidase of the apical membrane of intestinal epithelial
cells. Subsequent binding of adenosine to apical membrane
receptors promotes chloride secretion which, in turn, drives
isotonic fluid secretion [41]. A striking difference between the
intestinal model and the proximal tubule consists in that adeno-
sine must enter tubular cells to promote phosphaturia.
It should be mentioned that Coulson et al reported that
adenosine A1 receptor agonists stimulated phosphate and glucose
uptake in OK cells through a protein kinase C-sensitive pathway
[42]. These data are consistent with the observation made by
Balakrishnan, Coles and Williams that FK-453, a selective aden-
osine A1-receptor antagonist, promotes phosphaturia in healthy
human subjects [43]. The results of these different studies are not
conflicting: preventing adenosine entry into tubular cells may
increase available adenosine for binding to A1 receptors which, in
turn, mediate adenosine-induced phosphate reabsorption.
An other component of the complex effects of PTH on the
proximal tubule is the stimulation of ecto-5'-nucleotidase activity
[44]. This effect was demonstrated in OK cells: PTH increased
5'-AMP degradation into adenosine in a time-, concentration-,
and protein synthesis-dependent manner. Protein kinase C, but
not protein kinase A, was instrumental in this effect as evidenced
by stimulation of similar magnitude induced by (1-34) and (3-34)
fragments of PTH and by phorbol-myristate acetate, but not by
forskolin or dibutyryl cAMP [44]. Stimulation of 5'-nucleotidase
activity resulted in reinforcement of cAMP-induced inhibition of
phosphate transport.
In summary, luminal cAMP participates in the phosphaturic
effect of PTH which therefore has a triple action on proximal cells:
direct inhibitory effect on phosphate transport, generation of
cAMP which is mostly extruded in the luminal fluid, and, finally,
stimulation of luminal cAMP degradation through stimulation of
ecto-5'-nucleotidase (Fig. 1).
Luminal cGMP and chloride transport
As discussed earlier, interaction of ANP with glomerular epi-
thelial cells induces a release of cGMP in the urinary space [20].
This raises the possibility that luminal cGMP acts as a paracrine
modulator of tubular transport. This issue was examined in in vitro
microperfused, mouse medullaty thick ascending limbs of Henle's
loop (MAL) [45]. Addition of cGMP to the luminal fluid resulted
in a dramatic decrease of net chloride reabsorption and of
transepithelial potential difference. This effect appeared for
cGMP concentrations equal to or higher than 10 nM. Luminal
cGMP concentrations have been reported to reach such values
within minutes following systemic ANP infusion [18]. The effect of
luminal cGMP was not reproduced by addition of cGMP to the
basolateral bath and was not blocked by inhibitors of cGMP-
dependent protein kinase. The inhibition of transport induced by
luminal cGMP was additive with those elicited by ANP or
urodilatin which stimulated cGMP generation in MAL cells [45].
It is therefore unlikely that the effect of luminal cGMP was
exerted through entry of the nucleotide into the cells. Instead,
luminal cGMP may have bound to a membrane receptor or may
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(+) Cl— secretion
(+) K channels
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(—) Clreabsorption(+) C1 channels
(+)Lp
(—) AVP-induced
Lp
have activated an ecto-protein kinase such as that activated by
cAMP [46].
Whatever the cellular mechanism which underlies the inhibi-
tory effect of luminal cGMP on transport in Henle's loop, these
results strongly suggest that the overall natriuretic effect of ANP
is exerted, in part, by the cyclic nucleotide generated upstream in
glomerular epithelial cells and added to the tubular fluid.
These data illustrate the paracrine role of luminal cyclic nude-
otides, generated in the proximal part of the nephron, in down-
stream modulation of renal transport (Table 1). In addition, one
should keep in mind that adenosine, the major product of adenine
nucleotide metabolism, was reported to bind to different sub-
classes of membrane receptors in tubular cells from the proximal
tubule, the thick ascending limb of Henle's loop and the collecting
tubule [47—49] and to modulate transport in these segments [42,
43, 50—54] as well as in non-renal epithelia [55, 56]. Adenosine
receptors have been localized in both apical and basolateral
membranes of tubular cells. In rabbit cortical collecting duct cells,
apical A1 receptors activate apical chloride channels in a phos-
pholipase C-, protein kinase C- and pertussis toxin-sensitive
manner [51]. In contrast, adenosine-vasopressin antagonism in rat
inner medullary collecting duct involved basolateral A1 receptors
[52]. In LLC-PK1 cells, A1 receptors were detected in basolateral
membranes while A2 receptors were mainly distributed to apical
membranes [53]. These data illustrate the tubular effects of
adenosine which have to be taken into account as direct conse-
quences of release and degradation of adenine nucleotides.
Modulation of renal transport by extracellular ATP
The question of whether non-cyclic nucleotides might affect
membrane transport has been addressed in various cell types
including renal epithelial cells. Most of these studies examined the
role of extracellular ATP. The routes of ATP effiux have been
discussed above. An effect of extracellular ATP implies either its
catabolism into active products such as adenosine or its binding to
purinergic membrane receptors such as P2 receptors [2, 4, 5].
These receptors are coupled to a wide variety of cellular functions
such as calcium entry through ligand-activated calcium channels,
activation of Ca2-activated Kchannels, increase in intracellular
calcium and inositol phosphates, or opening of non-selective
8, 31 cation channels [4, 5, 57, 58]. The bulk of information concerning
the effects of ATP on signal transduction and membrane transport
34 in renal cells has been obtained cultured renal epithelial cell lines.
It should be stressed that, at present, no information is available
as regards the polarity (apical vs. basolateral) sites of action of
ATP.
Effect of extracellular A TP on second messenger pathways:
Phospholipase C-calcium and adenylate cyclase-cAMP
In LLC-PK1 cells, extracellular ATP was shown to modulate
intracellular calcium concentration [59]. ATP-induced calcium
transient was elicited by concentrations in the range of 1 to 100
jIM, occurred independently from the presence of calcium in the
incubation medium, was mimicked to a certain extent by ADP but
not by AMP or non-hydrolysable nucleotide analogs, and was not
blunted by xanthines. ATP did not stimulate cAMP generation
and the calcium response to ATP was not affected by prior
stimulation of cAMP synthesis by vasopressin, forskolin or cholera
toxin. Pretreatment of cells by pertussis toxin did not affect the
response to ATP. ATP was also shown to increase inositol
trisphosphate generation. These data suggest the presence of
P2/P2 purinergic receptors in this cell line, coupled to phospho-
lipase C by a pertussis toxin-insensitive G protein [59]. Similar
results were obtained in rat renal cortical cells [60] and in MDCK
cells, a renal cell line with distal phenotype, where P2-purinergic
receptors have been characterized [61].
That ATP, through P2-purinergic receptors, could modulate
cAMP generation was also demonstrated in LLC-PK1 cells [62].
Although ATP did not affect basal cAMP content in intact cells,
ATPyS, a non-hydrolysable ATP analogue with P2,, activity,
decreased basal, GTP-, forskolin-, and vasopressin-stimulated
adenylate cyclase activity of plasma membranes in a concentra-
tion-dependent manner (1 to 100 jIM). This inhibition was con-
firmed in intact cells. The effect of ATP was insensitive to
pertussis toxin but was blunted by GDPI3S, which suggests that the
inhibitory effect of ATP was mediated in part by a pertussis
toxin-insensitive G protein. While ATP, 1 nM to 1 jIM, activated
protein kinase C in a concentration-dependent manner, this
pathway was not involved in inhibition of adenylate cyclase
inasmuch as protein kinase C inhibitors did not change the effect
of ATP. However, one cannot rule out the possibility that
ATP-induced increase in cytosolic calcium concentration was
involved in this effect [62].
In contrast, activation of protein kiriase C was instrumental in
ATP modulation of epidermal growth factor (EGF) binding on
LLC-PK1 cells. ATP reduced EGF binding, an effect related to
the disappearance of high-affinity binding sites (Kd= 0.2 nM) while
the affinity and the number of low-affinity binding sites (Kd = 1.5
nM) were unchanged [63]. The effect of ATP was mimicked by
phorbol myristate acetate and was suppressed by down-regulation
or by pharmacological inhibition of protein kinase C. Up to now,
data are lacking concerning a possible modulation by ATP of
sodium and water transport in the collecting duct, a segment
which is a target for vasopressin and EGF.
Table 1. Source (in addition to the filtered moiety) and effect of
luminal nucleotides and nucleosides on transport in renal cells
69
65
66
50
51
77
77
Abbreviations are: AVP, arginine vasopressin; CCT, cortical collecting
tubule; Lp, hydraulic permeability; MAL, medullary thick ascending limb
of Henle's loop; PCT, proximal convoluted tubule; PST, proximal straight
tubule (pars recta); TAL, thick ascending limb of Henle's loop; (+)
denotes stimulation, (—) denotes inhibition.
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Extracellular A TP modulates chloride transport
In MDCK cells, ATP and UTP induced a sustained increase in
cytosolic calcium resulting from a combination of intracellular
calcium release and extracellular calcium entry [61, 64]. The
functional consequences of these cellular events were an increase
by ATP of transepithelial chloride secretion by confluent mono-
layers grown on permeant support [65]. This stimulation may have
been the consequence of sustained hyperpolarization which, in
turn, is related to opening of calcium-activated potassium chan-
nels [66]. This effect occurred for ATP concentrations in the
nanomolar/micromolar range and was mimicked by UTP and ITP
but not by AMP or adenosine, suggesting that P2-purinergic
receptors were instrumental in this response. Patch clamp analysis
of this phenomenon revealed that ATP increased in a fully
reversible manner the opening probability of inwardly rectifying
potassium channels. Again, a sustained activation of these chan-
nels required the presence of calcium in the extracellular medium
[66]. In A6 cells, a distal cell line from amphibian origin,
activation of P2-purinergic receptors lead to opening of chloride
channels and to chloride efflux. In turn, this increased chloride
exit resulted in activation of Na-K-Cl cotransport activity [67].
The stimulatory effect of extracellular ATP on chloride secre-
tion was also observed in nasal epithelium [68]. When applied to
the basolateral side of the epithelium, ATP induced cellular
hyperpolarization related to opening of potassium channels. This
hyperpolarization was the driving force for a modest increase in
chloride secretion, It is noteworthy that this effect was observed
only in normal nasal epithelium but not when cystic fibrosis was
present. Application of ATP at the apical side of the cells
efficiently stimulated chloride secretion, an effect related to direct
opening of apical chloride channels. Whether this event was
calcium-dependent was not firmly established. This effect was
observed in both normal and cystic fibrosis epithelia. These data
illustrate the concept that identical receptors may be linked to
different intracellular events and transduction pathways depend-
ing on their location in the plasma membrane.
Other transport systems modulated by extracellular A TP
As regards to a possible modulation of transport systems
expressed in proximal brush-border membranes, ATP stimulated
the transport of the organic cation tetraethylammonium [69]. The
effect of ATP was mimicked by GTP and ITP and required ATP
hydrolysis. The effect of ATP was blunted by organic cations and
did not involve ecto-ATPase, Nat, K -ATPase, H f -ATPase,
or Ca2-ATPase [69]. In contrast, ATP reduced organic anion
transport in rat hepatocytes [70]. This effect was not related to
P2/P2-purinergic receptor activity and required ATP hydrolysis.
There is no information concerning a putative effect of ATP on
renal organic anion transport. Clearly, these recent data argue
strongly in favor of modulatory effects of extracellular ATP on
epithelial transport, effects which are not exerted through the
"classic" P2 receptor pathway.
As discussed above ATP mimicked to a certain extent the
inhibitory effect of cAMP on Na-phosphate cotransport in prox-
imal cells [341. In contrast, a stimulatory effect of ATP on
Na-phosphate cotransport in cardiac myocytes has been reported
[71]. In turn, increased Na entry energized Na-Ca2 exchange
resulting in a calcium influx.
Other effects of extracellular A TP on renal cells
Mitogenic effects of ATP have been evidenced in renal [72, 73]
and non-renal [74] cells. As far as renal cells are concerned,
ATP-induced increased thymidine incorporation was observed in
primary cultures of proximal tubular cells [72] and of mesangial
cells [73]. In the latter, ATP potentiated the mitogenic effect of
other growth factors such as platelet-derived growth factor or
serotonin. The cellular pathways involved in the mitogenic effects
of ATP remain to be elucidated. Along the same line, adenine
nucleotides were shown to promote migration of cultured renal
epithelial cells. Adenosine, AMP, cAMP, ADP and ATP elicited
similar responses, raising the possibility that adenine nucleotides
are catabolized prior to producing their effect. These data argue in
favor of a role for extracellular nucleotides in renal regeneration
after acute tubular necrosis [75].
Finally, an indirect effect of ATP on renal transport, through
modulation of renal hemodynamics and tubuloglomerular feed-
back, was recently reported [76]. Infusion of 1 mrvi ATP in the
peritubular capillaries resulted in a drop of proximal stop-flow
pressure which reflected preglomerular vasoconstriction. This
effect was magnified during adenosine receptor blockade. ATP
also blunted the feedback response to late proximal infusion of
saline. The cellular mechanisms underlying these observations are
not clear. However, these data suggest that ATP may be a local
modulator of renal blood flow.
Conclusion
In this brief review, the modulatory effects of extracellular
nucleotides on transport in renal epithelium have been discussed.
A striking diversity has been demonstrated regarding the site and
mode of action of these compounds. Identification of genetic or
acquired abnormalities of these local loops, pharmacological
modulation of generation and/or metabolism or binding of extra-
cellular nucleotides are among the future goals in this new and
fascinating field of investigation in renal physiology and patho-
physiology.
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